Loading organizations...
§ Private Profile · 100 S Commons Ste 102, Pittsburgh, Pennsylvania, 15212, United States
Rimsys is a technology company.
Rimsys provides a specialized cloud-based Regulatory Information Management (RIM) platform for the medical technology industry. It centralizes regulatory data, automating crucial activities like global product registrations, submissions, and compliance with standards such as UDI. This streamlines operations, improving efficiency and reducing compliance risks for medtech manufacturers.
Founded in 2017, Rimsys was conceived by regulatory affairs professionals James Gianoutsos, CEO, and co-founder Brad Ryba. Their personal struggles with fragmented information, manual registrations, and dynamic regulations highlighted a significant gap in the market. This prompted them to create a purpose-built, automated solution for clarity and control in medtech compliance.
Rimsys serves medical technology companies, enabling them to confidently manage global regulatory compliance. The platform empowers manufacturers to proactively navigate complex, evolving regulatory environments. Its mission is to digitize, automate, and establish comprehensive regulatory order throughout the medtech sector, ensuring reliable compliance for its global clientele.
Rimsys has raised $19.5M across 3 funding rounds.
Rimsys has raised $19.5M in total across 3 funding rounds.
Rimsys is a Pittsburgh-based technology company founded in 2017 that develops cloud-based Regulatory Information Management (RIM) software specifically for medical device and medtech companies. Its platform digitizes and automates regulatory processes like product registrations, standards management, submissions, post-market surveillance, and regulatory intelligence, helping teams centralize data, boost productivity, reduce compliance risks, and accelerate global market launches.[1][2][3][5] Serving clients from startups to giants like Johnson & Johnson, Siemens Healthineers, and Omron, Rimsys addresses the chaos of manual spreadsheets and fragmented systems amid evolving regulations such as EU MDR/IVDR, with strong growth evidenced by a $16 million Series A in 2021 and adoption by 10 of the 30 largest medtech firms.[1][4][6]
Rimsys was founded in 2017 by regulatory affairs professionals, including President James Gianoutsos and CTO Brad Ryba, who were frustrated with inefficient practices like hunting for information in spreadsheets and manually tracking global registrations amid shifting regulations.[1][3] Their idea stemmed from a simple question: “Isn’t there a better way to do this?”—prompted by real-world struggles in RA teams.[3] Early traction built on this insider perspective, leading to a cloud-based platform hosted on AWS tailored for medtech workflows; by 2021, it secured $16M in Series A funding led by Bessemer Venture Partners, with participation from Allos Ventures and others, fueling expansion.[1]
Rimsys stands out as the first and only holistic RIM platform for medtech, replacing spreadsheets and consultants with a single, integrated system. Key strengths include:
Rimsys rides the wave of global regulatory complexity in medtech, where shifts like EU MDR/IVDR demand faster compliance amid rising standards and market fragmentation, outpacing manual methods.[3][5] Its timing aligns with digital transformation in healthcare, where cloud/AI tools automate RA to cut risks and speed launches—critical as medtech firms face overburdened teams and non-compliance penalties.[1][4] By partnering with consultants, distributors, and tech firms, Rimsys influences the ecosystem, enabling faster market entry for innovators and integrating with quality/clinical systems for end-to-end efficiency.[5][6]
Rimsys is poised for accelerated growth, leveraging its entrenched position with top medtech players and AI enhancements like Rimsys AI agents to dominate RIM amid ongoing regulatory upheavals.[4][5] Trends like AI-driven intelligence, ERP integrations, and expanding global markets (e.g., post-MDR waves) will propel it, potentially capturing more share as medtech scales to meet aging populations and innovation demands. Its influence may evolve into an indispensable backbone for RA, much like how it transformed spreadsheets into streamlined order—freeing teams to focus on breakthroughs rather than bureaucracy.[3][5]
Rimsys has raised $19.5M in total across 3 funding rounds.
Rimsys's investors include Bessemer Venture Partners, Allos Ventures, Atlas Venture, Better Tomorrow Ventures, Cincy Tech, Creacion Ventures, First Round Capital, Founders' Co-op, Innovation Works, Momenta Ventures, Monozukuri Ventures, Motivate Ventures.
Rimsys has raised $19.5M across 3 funding rounds. Most recently, it raised $16.0M Series A in December 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2021 | $16M Series A | Bessemer Venture Partners | Allos Ventures, Atlas Venture, Better Tomorrow Ventures, Cincy Tech, Creacion Ventures, First Round Capital, Founders' Co OP, Innovation Works, Momenta Ventures, Monozukuri Ventures, Motivate Ventures, RET Ventures, Vitalize Venture Group, Harrison Uffindell, Peter Moran, TED Driscoll, Private Opportunities | Announced |
| Aug 25, 2020 | $1.5M Venture Round | Allos Ventures | — | Announced |
| Aug 1, 2020 | $2M Seed | — | Allos Ventures, Cincy Tech, TED Driscoll | Announced |